Glenohumeral Internal Rotation Deficit (GIRD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by University Ghent.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Fund for Scientific Research, Flanders, Belgium
Information provided by (Responsible Party):
University Ghent
ClinicalTrials.gov Identifier:
NCT01422083
First received: August 22, 2011
Last updated: April 16, 2012
Last verified: April 2012
  Purpose

A loss of mobility in the shoulder in direction of internal rotation is associated with shoulder tendon pathology. Cause-effect relationship between these two is still not clear. It is suspected that this loss of mobility reduces the size of the tunnel in which this shoulder tendon is lying, namely the subacromial space. Overhead athletes frequently show glenohumeral internal rotation deficit (GIRD) while being healthy and free of shoulder pain. This makes this population interesting to investigate. This study wants to look at shoulders of overhead athletes with GIRD and measure the size of the subacromial space. After this, the athletes will be instructed to perform a home stretching program and at the end the effect of this on mobility and the size of the subacromial space will be measured.60 athletes will be recruited and randomly allocated to the control group and the stretching group. Before they start stretching, subacromial space size will be measured by use of ultrasound. This is a safe and non-invasive measuring tool. Mobility will be measured by use of a digital inclinometer. This also is safe and non-invasive. Patients will be instructed a stretching exercise, which they will be performing at home once a day during 6 weeks. At the end all outcome measures will be reassessed.


Condition Intervention
Glenohumeral Internal Rotation Deficit (GIRD)
Procedure: home stretching program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Prevention
Official Title: Correlation Between Loss of Internal Rotation Range of Motion and Size of the Subacromial Space and the Influence of a Home Stretching Program.

Further study details as provided by University Ghent:

Primary Outcome Measures:
  • Size of the subacromial space and shoulder mobility. [ Time Frame: at 0 weeks ] [ Designated as safety issue: No ]
    Measurment of the size of the subacromial space and shoulder mobility are performed by an ultrasound and an inclinometer.

  • Size of the subacromial space and shoulder mobility. [ Time Frame: after 6 weeks ] [ Designated as safety issue: No ]
    Measurment of the size of the subacromial space and shoulder mobility are performed by an ultrasound and an inclinometer.


Estimated Enrollment: 60
Study Start Date: September 2010
Estimated Study Completion Date: June 2012
Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control group
This group of athletes do not perform a 6-week stretching program.
Experimental: Home stretching program
These athletes take on a home stretching program (sleeper's stretch).
Procedure: home stretching program
A home stretching program (sleeper's stretch): 3 x 30 seconds, once a day for 6 weeks.

  Eligibility

Ages Eligible for Study:   18 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • overhead athletes: at least 3 hours/week training
  • male and female
  • 18-30 years of age
  • No shoulder pain during last 3 months for which a doctor was consulted
  • No shoulder surgery
  • No neck diseases

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01422083

Contacts
Contact: Ann Cools, Ph.D Ann.Cools@ugent.be
Contact: Annelies Maenhout, M. Sc. Annelies.Maenhout@ugent.be

Locations
Belgium
Ghent University Hospital Recruiting
Ghent, Belgium, 9000
Contact: Annelies Maenhout, M.Sc.       Annelies.Maenhout@ugent.be   
Principal Investigator: Ann Cools, Ph.D.         
Sub-Investigator: Annelies Maenhout, M.Sc.         
Sponsors and Collaborators
University Ghent
Fund for Scientific Research, Flanders, Belgium
Investigators
Principal Investigator: Ann Cools, Ph.D. Ghent University Hospital
  More Information

No publications provided

Responsible Party: University Ghent
ClinicalTrials.gov Identifier: NCT01422083     History of Changes
Other Study ID Numbers: 2010/372
Study First Received: August 22, 2011
Last Updated: April 16, 2012
Health Authority: Belgium: Ethics Committee

ClinicalTrials.gov processed this record on September 18, 2014